Ironwood Pharma (NASDAQ:IRWD)

CAPS Rating: 2 out of 5

Recs

1
Player Avatar Micrx (< 20) Submitted: 7/11/2012 9:22:05 AM : Outperform Start Price: $13.57 IRWD Score: -28.50

PDUFA date in next couple months. Drugs has a huge market with less effective competition.

Report this Post 1 Reply
Member Avatar BullDozeR2121 (< 20) Submitted: 8/3/2012 12:20:43 PM
Recs: 0

I agree with your statement albeit the competition part is slightly skewed. Synergy Pharma SGYPD has been working on a very similar product Plecanatide already in Stage 2b/3 efficacy testing slated to be released in the next year or two without the diarrhea side affects. I'd keep an eye out for them.

Report this Post

Featured Broker Partners


Advertisement